Global TB Disease Vaccine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global TB Disease Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for TB Disease Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for TB Disease Vaccine by Country/Region, 2017, 2022 & 2028

2.2 TB Disease Vaccine Segment by Type

2.2.1 Prevention Vaccines

2.2.2 Post-exposure Vaccines

2.2.3 Others

2.3 TB Disease Vaccine Sales by Type

2.3.1 Global TB Disease Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global TB Disease Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global TB Disease Vaccine Sale Price by Type (2017-2022)

2.4 TB Disease Vaccine Segment by Application

2.4.1 Self-Procurement

2.4.2 UNICEF

2.4.3 Others

2.5 TB Disease Vaccine Sales by Application

2.5.1 Global TB Disease Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global TB Disease Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global TB Disease Vaccine Sale Price by Application (2017-2022)

3 Global TB Disease Vaccine by Company

3.1 Global TB Disease Vaccine Breakdown Data by Company

3.1.1 Global TB Disease Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global TB Disease Vaccine Sales Market Share by Company (2020-2022)

3.2 Global TB Disease Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global TB Disease Vaccine Revenue by Company (2020-2022)

3.2.2 Global TB Disease Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global TB Disease Vaccine Sale Price by Company

3.4 Key Manufacturers TB Disease Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers TB Disease Vaccine Product Location Distribution

3.4.2 Players TB Disease Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for TB Disease Vaccine by Geographic Region

4.1 World Historic TB Disease Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global TB Disease Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global TB Disease Vaccine Annual Revenue by Geographic Region

4.2 World Historic TB Disease Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global TB Disease Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global TB Disease Vaccine Annual Revenue by Country/Region

4.3 Americas TB Disease Vaccine Sales Growth

4.4 APAC TB Disease Vaccine Sales Growth

4.5 Europe TB Disease Vaccine Sales Growth

4.6 Middle East & Africa TB Disease Vaccine Sales Growth

5 Americas

5.1 Americas TB Disease Vaccine Sales by Country

5.1.1 Americas TB Disease Vaccine Sales by Country (2017-2022)

5.1.2 Americas TB Disease Vaccine Revenue by Country (2017-2022)

5.2 Americas TB Disease Vaccine Sales by Type

5.3 Americas TB Disease Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC TB Disease Vaccine Sales by Region

6.1.1 APAC TB Disease Vaccine Sales by Region (2017-2022)

6.1.2 APAC TB Disease Vaccine Revenue by Region (2017-2022)

6.2 APAC TB Disease Vaccine Sales by Type

6.3 APAC TB Disease Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe TB Disease Vaccine by Country

7.1.1 Europe TB Disease Vaccine Sales by Country (2017-2022)

7.1.2 Europe TB Disease Vaccine Revenue by Country (2017-2022)

7.2 Europe TB Disease Vaccine Sales by Type

7.3 Europe TB Disease Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa TB Disease Vaccine by Country

8.1.1 Middle East & Africa TB Disease Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa TB Disease Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa TB Disease Vaccine Sales by Type

8.3 Middle East & Africa TB Disease Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of TB Disease Vaccine

10.3 Manufacturing Process Analysis of TB Disease Vaccine

10.4 Industry Chain Structure of TB Disease Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 TB Disease Vaccine Distributors

11.3 TB Disease Vaccine Customer

12 World Forecast Review for TB Disease Vaccine by Geographic Region

12.1 Global TB Disease Vaccine Market Size Forecast by Region

12.1.1 Global TB Disease Vaccine Forecast by Region (2023-2028)

12.1.2 Global TB Disease Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global TB Disease Vaccine Forecast by Type

12.7 Global TB Disease Vaccine Forecast by Application

13 Key Players Analysis

13.1 Merck

13.1.1 Merck Company Information

13.1.2 Merck TB Disease Vaccine Product Offered

13.1.3 Merck TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Merck Main Business Overview

13.1.5 Merck Latest Developments

13.2 Japan BCG Lab

13.2.1 Japan BCG Lab Company Information

13.2.2 Japan BCG Lab TB Disease Vaccine Product Offered

13.2.3 Japan BCG Lab TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Japan BCG Lab Main Business Overview

13.2.5 Japan BCG Lab Latest Developments

13.3 Serum Institute of India

13.3.1 Serum Institute of India Company Information

13.3.2 Serum Institute of India TB Disease Vaccine Product Offered

13.3.3 Serum Institute of India TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Serum Institute of India Main Business Overview

13.3.5 Serum Institute of India Latest Developments

13.4 AJ Vaccines

13.4.1 AJ Vaccines Company Information

13.4.2 AJ Vaccines TB Disease Vaccine Product Offered

13.4.3 AJ Vaccines TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 AJ Vaccines Main Business Overview

13.4.5 AJ Vaccines Latest Developments

13.5 BioFarma

13.5.1 BioFarma Company Information

13.5.2 BioFarma TB Disease Vaccine Product Offered

13.5.3 BioFarma TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 BioFarma Main Business Overview

13.5.5 BioFarma Latest Developments

13.6 GreenSignal Bio Pharma

13.6.1 GreenSignal Bio Pharma Company Information

13.6.2 GreenSignal Bio Pharma TB Disease Vaccine Product Offered

13.6.3 GreenSignal Bio Pharma TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 GreenSignal Bio Pharma Main Business Overview

13.6.5 GreenSignal Bio Pharma Latest Developments

13.7 China National Biotec

13.7.1 China National Biotec Company Information

13.7.2 China National Biotec TB Disease Vaccine Product Offered

13.7.3 China National Biotec TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 China National Biotec Main Business Overview

13.7.5 China National Biotec Latest Developments

13.8 Biomed Lublin

13.8.1 Biomed Lublin Company Information

13.8.2 Biomed Lublin TB Disease Vaccine Product Offered

13.8.3 Biomed Lublin TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Biomed Lublin Main Business Overview

13.8.5 Biomed Lublin Latest Developments

13.9 Taj Pharmaceuticals

13.9.1 Taj Pharmaceuticals Company Information

13.9.2 Taj Pharmaceuticals TB Disease Vaccine Product Offered

13.9.3 Taj Pharmaceuticals TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Taj Pharmaceuticals Main Business Overview

13.9.5 Taj Pharmaceuticals Latest Developments

13.10 Ataulpho de Paiva

13.10.1 Ataulpho de Paiva Company Information

13.10.2 Ataulpho de Paiva TB Disease Vaccine Product Offered

13.10.3 Ataulpho de Paiva TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Ataulpho de Paiva Main Business Overview

13.10.5 Ataulpho de Paiva Latest Developments

13.11 IVAC

13.11.1 IVAC Company Information

13.11.2 IVAC TB Disease Vaccine Product Offered

13.11.3 IVAC TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 IVAC Main Business Overview

13.11.5 IVAC Latest Developments

13.12 Queen Saovabha Mem. Inst

13.12.1 Queen Saovabha Mem. Inst Company Information

13.12.2 Queen Saovabha Mem. Inst TB Disease Vaccine Product Offered

13.12.3 Queen Saovabha Mem. Inst TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Queen Saovabha Mem. Inst Main Business Overview

13.12.5 Queen Saovabha Mem. Inst Latest Developments

13.13 Microgen

13.13.1 Microgen Company Information

13.13.2 Microgen TB Disease Vaccine Product Offered

13.13.3 Microgen TB Disease Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Microgen Main Business Overview

13.13.5 Microgen Latest Developments

14 Research Findings and Conclusion

Table 1. TB Disease Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. TB Disease Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Prevention Vaccines

Table 4. Major Players of Post-exposure Vaccines

Table 5. Major Players of Others

Table 6. Global TB Disease Vaccine Sales by Type (2017-2022) & (K Units)

Table 7. Global TB Disease Vaccine Sales Market Share by Type (2017-2022)

Table 8. Global TB Disease Vaccine Revenue by Type (2017-2022) & ($ million)

Table 9. Global TB Disease Vaccine Revenue Market Share by Type (2017-2022)

Table 10. Global TB Disease Vaccine Sale Price by Type (2017-2022) & (US$/Unit)

Table 11. Global TB Disease Vaccine Sales by Application (2017-2022) & (K Units)

Table 12. Global TB Disease Vaccine Sales Market Share by Application (2017-2022)

Table 13. Global TB Disease Vaccine Revenue by Application (2017-2022)

Table 14. Global TB Disease Vaccine Revenue Market Share by Application (2017-2022)

Table 15. Global TB Disease Vaccine Sale Price by Application (2017-2022) & (US$/Unit)

Table 16. Global TB Disease Vaccine Sales by Company (2020-2022) & (K Units)

Table 17. Global TB Disease Vaccine Sales Market Share by Company (2020-2022)

Table 18. Global TB Disease Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 19. Global TB Disease Vaccine Revenue Market Share by Company (2020-2022)

Table 20. Global TB Disease Vaccine Sale Price by Company (2020-2022) & (US$/Unit)

Table 21. Key Manufacturers TB Disease Vaccine Producing Area Distribution and Sales Area

Table 22. Players TB Disease Vaccine Products Offered

Table 23. TB Disease Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global TB Disease Vaccine Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global TB Disease Vaccine Sales Market Share Geographic Region (2017-2022)

Table 28. Global TB Disease Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global TB Disease Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global TB Disease Vaccine Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global TB Disease Vaccine Sales Market Share by Country/Region (2017-2022)

Table 32. Global TB Disease Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global TB Disease Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas TB Disease Vaccine Sales by Country (2017-2022) & (K Units)

Table 35. Americas TB Disease Vaccine Sales Market Share by Country (2017-2022)

Table 36. Americas TB Disease Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas TB Disease Vaccine Revenue Market Share by Country (2017-2022)

Table 38. Americas TB Disease Vaccine Sales by Type (2017-2022) & (K Units)

Table 39. Americas TB Disease Vaccine Sales Market Share by Type (2017-2022)

Table 40. Americas TB Disease Vaccine Sales by Application (2017-2022) & (K Units)

Table 41. Americas TB Disease Vaccine Sales Market Share by Application (2017-2022)

Table 42. APAC TB Disease Vaccine Sales by Region (2017-2022) & (K Units)

Table 43. APAC TB Disease Vaccine Sales Market Share by Region (2017-2022)

Table 44. APAC TB Disease Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC TB Disease Vaccine Revenue Market Share by Region (2017-2022)

Table 46. APAC TB Disease Vaccine Sales by Type (2017-2022) & (K Units)

Table 47. APAC TB Disease Vaccine Sales Market Share by Type (2017-2022)

Table 48. APAC TB Disease Vaccine Sales by Application (2017-2022) & (K Units)

Table 49. APAC TB Disease Vaccine Sales Market Share by Application (2017-2022)

Table 50. Europe TB Disease Vaccine Sales by Country (2017-2022) & (K Units)

Table 51. Europe TB Disease Vaccine Sales Market Share by Country (2017-2022)

Table 52. Europe TB Disease Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe TB Disease Vaccine Revenue Market Share by Country (2017-2022)

Table 54. Europe TB Disease Vaccine Sales by Type (2017-2022) & (K Units)

Table 55. Europe TB Disease Vaccine Sales Market Share by Type (2017-2022)

Table 56. Europe TB Disease Vaccine Sales by Application (2017-2022) & (K Units)

Table 57. Europe TB Disease Vaccine Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa TB Disease Vaccine Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa TB Disease Vaccine Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa TB Disease Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa TB Disease Vaccine Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa TB Disease Vaccine Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa TB Disease Vaccine Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa TB Disease Vaccine Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa TB Disease Vaccine Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of TB Disease Vaccine

Table 67. Key Market Challenges & Risks of TB Disease Vaccine

Table 68. Key Industry Trends of TB Disease Vaccine

Table 69. TB Disease Vaccine Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. TB Disease Vaccine Distributors List

Table 72. TB Disease Vaccine Customer List

Table 73. Global TB Disease Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global TB Disease Vaccine Sales Market Forecast by Region

Table 75. Global TB Disease Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global TB Disease Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas TB Disease Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas TB Disease Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC TB Disease Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC TB Disease Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe TB Disease Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe TB Disease Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa TB Disease Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa TB Disease Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global TB Disease Vaccine Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global TB Disease Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 87. Global TB Disease Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global TB Disease Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global TB Disease Vaccine Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global TB Disease Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 91. Global TB Disease Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global TB Disease Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 93. Merck Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 94. Merck TB Disease Vaccine Product Offered

Table 95. Merck TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 96. Merck Main Business

Table 97. Merck Latest Developments

Table 98. Japan BCG Lab Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 99. Japan BCG Lab TB Disease Vaccine Product Offered

Table 100. Japan BCG Lab TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. Japan BCG Lab Main Business

Table 102. Japan BCG Lab Latest Developments

Table 103. Serum Institute of India Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 104. Serum Institute of India TB Disease Vaccine Product Offered

Table 105. Serum Institute of India TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. Serum Institute of India Main Business

Table 107. Serum Institute of India Latest Developments

Table 108. AJ Vaccines Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 109. AJ Vaccines TB Disease Vaccine Product Offered

Table 110. AJ Vaccines TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. AJ Vaccines Main Business

Table 112. AJ Vaccines Latest Developments

Table 113. BioFarma Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 114. BioFarma TB Disease Vaccine Product Offered

Table 115. BioFarma TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 116. BioFarma Main Business

Table 117. BioFarma Latest Developments

Table 118. GreenSignal Bio Pharma Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 119. GreenSignal Bio Pharma TB Disease Vaccine Product Offered

Table 120. GreenSignal Bio Pharma TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 121. GreenSignal Bio Pharma Main Business

Table 122. GreenSignal Bio Pharma Latest Developments

Table 123. China National Biotec Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 124. China National Biotec TB Disease Vaccine Product Offered

Table 125. China National Biotec TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 126. China National Biotec Main Business

Table 127. China National Biotec Latest Developments

Table 128. Biomed Lublin Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 129. Biomed Lublin TB Disease Vaccine Product Offered

Table 130. Biomed Lublin TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 131. Biomed Lublin Main Business

Table 132. Biomed Lublin Latest Developments

Table 133. Taj Pharmaceuticals Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 134. Taj Pharmaceuticals TB Disease Vaccine Product Offered

Table 135. Taj Pharmaceuticals TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 136. Taj Pharmaceuticals Main Business

Table 137. Taj Pharmaceuticals Latest Developments

Table 138. Ataulpho de Paiva Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 139. Ataulpho de Paiva TB Disease Vaccine Product Offered

Table 140. Ataulpho de Paiva TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 141. Ataulpho de Paiva Main Business

Table 142. Ataulpho de Paiva Latest Developments

Table 143. IVAC Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 144. IVAC TB Disease Vaccine Product Offered

Table 145. IVAC TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 146. IVAC Main Business

Table 147. IVAC Latest Developments

Table 148. Queen Saovabha Mem. Inst Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 149. Queen Saovabha Mem. Inst TB Disease Vaccine Product Offered

Table 150. Queen Saovabha Mem. Inst TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 151. Queen Saovabha Mem. Inst Main Business

Table 152. Queen Saovabha Mem. Inst Latest Developments

Table 153. Microgen Basic Information, TB Disease Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 154. Microgen TB Disease Vaccine Product Offered

Table 155. Microgen TB Disease Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 156. Microgen Main Business

Table 157. Microgen Latest Developments

List of Figures

Figure 1. Picture of TB Disease Vaccine

Figure 2. TB Disease Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global TB Disease Vaccine Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global TB Disease Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. TB Disease Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Prevention Vaccines

Figure 10. Product Picture of Post-exposure Vaccines

Figure 11. Product Picture of Others

Figure 12. Global TB Disease Vaccine Sales Market Share by Type in 2021

Figure 13. Global TB Disease Vaccine Revenue Market Share by Type (2017-2022)

Figure 14. TB Disease Vaccine Consumed in Self-Procurement

Figure 15. Global TB Disease Vaccine Market: Self-Procurement (2017-2022) & (K Units)

Figure 16. TB Disease Vaccine Consumed in UNICEF

Figure 17. Global TB Disease Vaccine Market: UNICEF (2017-2022) & (K Units)

Figure 18. TB Disease Vaccine Consumed in Others

Figure 19. Global TB Disease Vaccine Market: Others (2017-2022) & (K Units)

Figure 20. Global TB Disease Vaccine Sales Market Share by Application (2017-2022)

Figure 21. Global TB Disease Vaccine Revenue Market Share by Application in 2021

Figure 22. TB Disease Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 23. Global TB Disease Vaccine Revenue Market Share by Company in 2021

Figure 24. Global TB Disease Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global TB Disease Vaccine Revenue Market Share by Geographic Region in 2021

Figure 26. Global TB Disease Vaccine Sales Market Share by Region (2017-2022)

Figure 27. Global TB Disease Vaccine Revenue Market Share by Country/Region in 2021

Figure 28. Americas TB Disease Vaccine Sales 2017-2022 (K Units)

Figure 29. Americas TB Disease Vaccine Revenue 2017-2022 ($ Millions)

Figure 30. APAC TB Disease Vaccine Sales 2017-2022 (K Units)

Figure 31. APAC TB Disease Vaccine Revenue 2017-2022 ($ Millions)

Figure 32. Europe TB Disease Vaccine Sales 2017-2022 (K Units)

Figure 33. Europe TB Disease Vaccine Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa TB Disease Vaccine Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa TB Disease Vaccine Revenue 2017-2022 ($ Millions)

Figure 36. Americas TB Disease Vaccine Sales Market Share by Country in 2021

Figure 37. Americas TB Disease Vaccine Revenue Market Share by Country in 2021

Figure 38. United States TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC TB Disease Vaccine Sales Market Share by Region in 2021

Figure 43. APAC TB Disease Vaccine Revenue Market Share by Regions in 2021

Figure 44. China TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 48. India TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe TB Disease Vaccine Sales Market Share by Country in 2021

Figure 51. Europe TB Disease Vaccine Revenue Market Share by Country in 2021

Figure 52. Germany TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. France TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa TB Disease Vaccine Sales Market Share by Country in 2021

Figure 58. Middle East & Africa TB Disease Vaccine Revenue Market Share by Country in 2021

Figure 59. Egypt TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country TB Disease Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of TB Disease Vaccine in 2021

Figure 65. Manufacturing Process Analysis of TB Disease Vaccine

Figure 66. Industry Chain Structure of TB Disease Vaccine

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles